Today’s Hot List: Facebook Inc (NASDAQ:FB), Hemispherx Biopharma (NYSEMKT:HEB), Ford Motor Company (NYSE:F), AerCap Holdings N.V. (NYSE:AER), Johnson & Johnson (NYSE:JNJ)

On Tuesday shares of Facebook Inc (NASDAQ:FB) closed at $77.46. Company’s sales growth for last 5 years was 74.20% and EPS growth for next 5 years is recorded as 27.28%. Facebook Inc (NASDAQ:FB) is reportedly testing out a new feature that would allow users to search for and share links directly from within the Facebook mobile app.

Hemispherx Biopharma, Inc. (NYSEMKT:HEB) in last trading activity advanced 3.08% to close at $0.27. Company weekly performance is -0.74% while its quarterly performance stands at 16.52%. Hemispherx Biopharma, Inc. (NYSEMKT:HEB) is -33.00% away from its 52 week high. Hemispherx Biopharma, Inc. (NYSEMKT:HEB) said its European subsidiary, Hemispherx Biopharma Europe N.V./S.A., received formal notification from the European Commission approving its Orphan Medicinal Product Application for Ampligen, an experimental therapeutic, to treat Ebola Virus Disease.

On last trading day Ford Motor Company (NYSE:F) moved down -0.58% to close at $15.56. Its volatility for the week is 1.49% while volatility for the month is 1.34%. F’s sales growth for past 5 years was 4.40% and its EPS growth for past 5 years was -1.40%. Ford Motor Company (NYSE:F) monthly performance is -1.03%. Ford Motor Company (NYSE:F) has issued another recall — its second — for its all-new aluminum-bodied F-150 pickup truck.

AerCap Holdings N.V. (NYSE:AER) has 0.40% insider ownership while its institutional ownership stands at 33.80%. In last trading activity company’s stock closed at $48.48. AerCap Holdings NV (NYSE:AER) 104 aircraft transactions executed including the purchase of 17 aircraft with a value of $1.3 billion. Fleet utilization rate of 99.4%; 7.6 year average age of the owned fleet; and average remaining contracted lease term of 5.9 years.

On Tuesday shares of Johnson & Johnson (NYSE:JNJ) closed at $100.47. Company’s sales growth for last 5 years was 3.70% and EPS growth for next 5 years is recorded as 5.13%. Johnson & Johnson (NYSE:JNJ) said on 7 May, it has entered into a “first-of-its-kind partnership,” which enlists a third party to review requests made for compassionate use of its investigation medicines.

Leave a Reply

Your email address will not be published. Required fields are marked *